摘要
目的:研究黄芩苷(Baicalin)对金黄色葡萄球菌肺炎小鼠的保护作用。方法:建立体内金葡菌感染肺炎小鼠模型,检测通过黄芩苷治疗后模型小鼠死亡率、肺湿/干重比例、菌落定植数以及肺泡灌洗液内细胞因子的变化。结果:黄芩苷能够显著降低金葡菌肺炎小鼠的死亡率,小鼠肺脏金葡菌的定植数量及肺脏湿重/干重比;肺泡灌洗液分析试验结果表明,黄芩苷治疗显著减少肺泡灌洗液中主要炎症因子TNF-α、IL-1β和IL-6的含量。结论:黄芩苷可有效治疗小鼠金葡菌肺炎,同时为创新性抗感染药物的研发奠定坚实的基础。
Objective:This study aim to evaluate the effects of baicalin to Staphylococcus aureus(S. aureus) in mice. Methods:The mouse model of S. aurues pneumonia was established to assess the in vivo performance of baicalin, the mortality, lung wet-dry ratio, bacterial count and alteration of cytokine were studied. Results:The results showed that treated mice with baicalin significantly decreased the mortality and the colony forming units (CFUs) in the lung tissues. The lung wet-dry ratio was also reduced, indicating that the pulmonary edema was alleviated. Analysis of bronchoalveolar lavage (BAL)fluid revealed that treated mice with baicalin led to a marked reduction in IL-1β, TNF-α and IL-6 concentrations in BAL fluids. Conclusion:The findings in our study indicated that baicalin protects lung damage from S. aureus, and our study will lay the foundation for development of?innovative?anti-infective drugs.
出处
《北方药学》
2014年第6期65-67,共3页
Journal of North Pharmacy
基金
黑龙江省教育厅研究生创新科研项目
编号:YJSCX2011-246HLJ